Akamatsu H, Teraoka S, Takamori S, Miura S, et al. Nivolumab retreatment in non-small cell lung cancer patients who responded to prior immune-checkpoint inhibitors and had ICI-free intervals (WJOG9616L). Clin Cancer Res 2022 May 26. pii: 699251. doi: 10.1158/1078-0432.CCR-22-0602.
PMID: 35617519